{"url_path":"/sec/sgmo/8-k/2026-03-30/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-03-30","source_url":"https://www.sec.gov/Archives/edgar/data/1001233/0001628280-26-022006-index.html","accession_number":"0001628280-26-022006","cik":"0001001233","ticker":"SGMO","issuer_name":"SANGAMO THERAPEUTICS, INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1001233/0001628280-26-022006-index.html","primary_entity_key":"0001001233","primary_entity_name":"SANGAMO THERAPEUTICS, INC"},"word_count":86,"has_tables":true,"body_markdown":"Item 9.01 Financial Statements and Exhibits.\n\n(d) Exhibits.\n\n \n\nExhibit\nNo.  Description\n\n99.1   \n[Press Release regarding financial results dated](exhibit-991033026.htm)[March 30, 2026](exhibit-991033026.htm)\n\n104 Cover Page Interactive Data File (embedded within the Inline XBRL document)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n  SANGAMO THERAPEUTICS, INC.\n\nDated: March 30, 2026  By: /s/ SCOTT B. WILLOUGHBY\n\n  Name: Scott B. Willoughby\n\n  Title: Chief Legal Officer and Corporate Secretary"}